The Prostate Cancer Center for Excellence was established in 1999 as a center for innovative research and treatment of prostate cancer. The Center fosters important multidisciplinary research through integration, collaboration and translation within the Comprehensive Cancer Center programs.

Research

To achieve the greatest impact on reducing mortality and morbidity from prostate cancer, our research is focused on 3 main areas.

• Chemoprevention
• Identification of risk factors for the disease or its recurrence
• Development of new therapies for men with existing prostate cancer

---

 

Chemoprevention

Chemoprevention is the use of natural or synthetic agents to reduce the risk of cancer. Studies are being conducted on soy protein with isoflavones and vitamin D as preventive agents.

Identifying Risk Factors

Risk factor research involves examining abnormalities at the cellular and molecular level that contribute to increased risk for the disease.

New Therapies

Among the new therapies being explored are the use of dendritic (immune) cells and vitamin D to fight prostate cancer.

Clinical Treatment

In clinical treatment, we have brought together experts in genitourinary medical oncology, radiation oncology, urologic oncology, pathology and radiology in a unique and comprehensive multidisciplinary clinic.

Through this weekly clinic, our Genitourinary Oncology Group provides assessment of all new patients to determine the most effective treatment program including initial treatment, long-term follow-up and quality of life issues. Our multidisciplinary clinic sees patients with prostate, bladder, testicular, adrenal and other related cancers.